SEARCH

SEARCH BY CITATION

References

  • 1
    Cassidy JT, Petty RE. Textbook of pediatric rheumatology, 4th edn. Philadelphia: W.B. Saunders Company, 2001: 56974.
  • 2
    Behrman RE, Kliegman RM, Jenson HB. Nelson textbook of pediatrics, 16th edn. Philadelphia: W.B. Saunders Company, 2000: 7289.
  • 3
    Knight JF. The rheumatic poison: a survey of some published investigations of the immunopathogenesis of Henoch–Schönlein purpura. Pediatr Nephrol 1990; 4: 53341.
  • 4
    Faille-Kuyber EH, Kater L, Kooiker CJ, Dorhout Mees EJ. IgA-deposits in cutaneous blood-vessel walls and mesangium in Henoch–Schönlein syndrome. Lancet 1973; 1: 8923.
  • 5
    Yang YH, Huang MT, Lin SC, Lin YT, Tsai MJ, Chiang BL. Increased TGF-α secreting T cells and IgA anticardiolipin antibodies levels during acute stage of childhood Henoch–Schönlein purpura. Clin Exp Immunol 2000; 122: 28590.
  • 6
    Belizna C, Tervaert JWC. Specificity, pathogenecity, and clinical value of antiendothelial cell antibodies. Semin Arthritis Rheum 1997; 27: 98109.
  • 7
    Praprotnik S, Blank K, Meroni PL, Rozman B, Eldor A, Schoenfeld Y. Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells. Arthritis Rheum 2001; 44: 148494.
  • 8
    Leung DYM, Collins T, Lapierre LA, Geha RS, Pober JS. Immunoglobulin M antibodies present in the acute phase Kawasaki syndrome lyse cultured vascular endothelial cells stimulated by gamma interferon. J Clin Invest 1986; 77: 142835.
  • 9
    Tizard EJ, Baguley E, Hughes GRV, Dillon M. Antiendothelial cell antibodies detected by a cellular based ELISA in Kawasaki disease. Arch Dis Child 1991; 66: 18992.
  • 10
    Kaneko K, Savage COS, Pottinger BE, Shah V, Pearson JD, Dillon M. Antiendothelial cell antibodies can be cytotoxic to endothelial cells without cytokine pre-treatment and correlate with ELISA antibody measurement  in  Kawasaki  disease. Clin  Exp  Immunol 1994;  98: 2649.
  • 11
    Savage COS, Pottinger BE, Gaskin G, Lockwood CM, Pusey CD, Pearson JD. Vascular damage in Wegener's granulomatosis and microscopic polyarteritis: presence of anti-endothelial cell antibodies and their relation to anti-neutrophil cytoplasm antibodies. Clin Exp Immunol 1991; 85: 149.
  • 12
    Tripathy NK, Upadhyaya S, Sinha N, Nityanand S. Complement and cell mediated cytotoxicity by antiendothelial cell antibodies in Takayasu's arteritis. J Rheumatol 2001; 28: 8058.
  • 13
    Jaffe EA, Nachman RL, Becker CG, Minick RC. Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52: 274556.
  • 14
    George J, Meroni PL, Gilburd B, Raschi E, Harats D, Shoenfeld Y. Anti-endothelial cell antibodies in patients with coronary atherosclerosis. Immunol Lett 2000; 73: 237.
  • 15
    Wangel AG, Kontianen S, Scenini T, Schlenzka A, Wangel D, ­Maenpaa J. Anti-endothelial cell antibodies in insulin-dependent ­diabetes mellitus. Clin Exp Immunol 1992; 88: 4103.
  • 16
    Tixier D, Tuso P, Czer L et al. Characterization of antiendothelial cell and antiheart antibodies following heart transplantation. Transpl Proc 1993; 25: 9314.
  • 17
    Chan TM, Frampton G, Jayne DR, Perry GJ, Lockwood CM, Cameron JS. Clinical significance of anti-endothelial cell antibodies in systemic vasculitis: a longitudinal study comparing anti-endothelial cell antibodies and anti-neutrophil cytoplasmic antibodies. Am J Kidney Dis 1993; 22: 38792.
  • 18
    Rosenbaum J, Pottinger BE, Woo P et al. Measurement and characterization of circulating anti-endothelial cell IgG in connective tissue diseases. Clin Exp Immunol 1988; 72: 4506.
  • 19
    Fujieda M, Oishi N, Kurashige T. Antibodies to endothelial cells in Kawasaki disease lyse endothelial cells without cytokine pretreatment. Clin Exp Immunol 1997; 107: 1206.
  • 20
    Fujieda M, Oishi N, Naruse K et al. Soluble thrombomodulin and antibodies to bovine glomerular endothelial cells in patients with Henoch–Schönlein purpura. Arch Dis Child 1998; 78: 2404.
  • 21
    Wines BD, Sardjono CT, Trist HH, Lay CS, Hogarth PM. The interaction of Fc alpha RI with IgA and its implications for ligand binding by immunoreceptors of the leukocyte receptor cluster. J Immunol 2001; 163: 17819.
  • 22
    Zhang W, Oldroyd RG, Lachmann PJ. Neutrophil lactoferrin release induced by IgA immune complexes differed from that induced by cross-linking of fcalpha receptors (FcalphaR) with a monoclonal antibody, MIP8a. Clin Exp Immunol 2000; 121: 10611.
  • 23
    Parslow TG, Stites DP, Terr AI, Imboden JB. Medical immunology, 10th edn . New York: Lange Medical Books/McGraw-Hill Medical Publishing Division, 2001: 14854.
  • 24
    Besbas N, Saatci U, Ruacan S, Ozen S, Sungur A, Bakkaloglu A, Elnahas AM. The role of cytokines in Henoch–Schönlein purpura. Scand J Rheumatol 1997; 26: 45660.
  • 25
    Gattorno M, Vignola S, Barbano G et al. Tumor necrosis factor induced adhesion molecule serum concentrations in Henoch–Schönlein purpura and pediatric systemic lupus erythematosus. J Rheumatol 2000; 27: 22515.